Enveric Biosciences Inc (ENVB NASDAQ) stock market data APIs
$1.9799
0.01(0.5%)
as of March 25, 2026
Try our APIs with
free plan!
Enveric Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.
Prev. Close
1.9799
Open
1.9935
High
2.0362
Low
1.977
52 wk Range
1.82-19.2
Market Cap
2 830 K
Shares Outstanding
518 K
Revenue
35 405 K
EPS
-10.81
Beta
0.276
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Enveric Biosciences Inc data using free add-ons & libraries
Get Enveric Biosciences Inc Fundamental Data
Enveric Biosciences Inc Fundamental data includes:
- Net Revenue: 35 405 K
- EBITDA: -9 675 295
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-14
- EPS/Forecast: -0.35
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Enveric Biosciences Inc News
New
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Organigram Secured C$65.2 Million Strategic Investment from British American Tobacco After the Company Agreed to Acquire Sanity Group Canopy Growth Secured Shareholder ...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Cronos Acquired Europe’s Largest Adult-use Cannabis Company Aurora Introduced a New Proprietary Cultivar to Polish Market Trulieve Redeemed Costly 2026 Senior Secured...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Village Farms Broke New Ground with Vape Launch in Quebec Organigram Announced Former BAT Strategy Chief as New CEO MTL Cannabis Posted Solid Second Quarter Results wit...
Enveric Biosciences GAAP EPS of -$10.81
* Enveric Biosciences press release [https://seekingalpha.com/pr/20308638-enveric-biosciences-reports-third-quarter-2025-financial-and-corporate-results] (ENVB [https://seekingalpha.com/symbol/ENVB]...
Get Enveric Biosciences Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
